ArticleMedicina (Kaunas, Lithuania)2025
Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study.
Furkan Ceylan, Selin Aktürk Esen, Olçun Ümit Ünal, Ferit Aslan, İlknur Deliktaş Onur, Öztürk Ateş, Erkut Demirciler, İlkay Tuğba Ünek, Ahmet Gülmez, Esra Özen Engin and 11 more
Abstract readMulticenter Study
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
21 authors.
Furkan CeylanDepartment of Medical Oncology, Ankara Bilkent City Hospital, Ankara 06800, Turkey.
Selin Aktürk EsenDepartment of Medical Oncology, Ankara Bilkent City Hospital, Ankara 06800, Turkey.
Olçun Ümit ÜnalDepartment of Medical Oncology, UHS Izmir Faculty of Medicine, Izmir 35020, Turkey.
Ferit AslanDepartment of Medical Oncology, Ankara Batıkent Medical Park Hospital, Ankara 06680, Turkey.ORCID 0000-0002-9153-6921 İlknur Deliktaş OnurDepartment of Medical Oncology, A.Y. Ankara Oncology Training and Research Hospital, Ankara 06200, Turkey.ORCID 0000-0001-9884-5789 Öztürk AteşDepartment of Medical Oncology, A.Y. Ankara Oncology Training and Research Hospital, Ankara 06200, Turkey.ORCID 0000-0003-0182-3933 Esra Özen EnginDepartment of Medical Oncology, Sakarya Training and Research Hospital, Sakarya 54100, Turkey.
Semra TaşDepartment of Medical Oncology, Pamukkale University, Denizli 20070, Turkey.
Gamze Gököz DoğuDepartment of Medical Oncology, Pamukkale University, Denizli 20070, Turkey.
Hacı Mehmet TürkDepartment of Medical Oncology, Bezmialem University, Istanbul 34093, Turkey.
Ali İnalDepartment of Medical Oncology, Mersin City Hospital, Mersin 33330, Turkey.
Mutlu HızalDepartment of Medical Oncology, Ankara Bilkent City Hospital, Ankara 06800, Turkey.
Mehmet Ali Nahit ŞendurDepartment of Medical Oncology, Ankara Bilkent City Hospital, Ankara 06800, Turkey.ORCID 0000-0001-7021-6139 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Colorectal NeoplasmsInduction ChemotherapyLiver NeoplasmsAdultAgedFemaleFluorouracilHepatectomyHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeTurkeyFluorouracilanti-EGFR therapyanti-VEGF therapyconversion surgeryinduction chemotherapyliver metastasismetastatic colorectal cancer
Identifiers
PMID40428735
PMCPMC12113550
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390